Congenital anomalies after prenatal ecstasy exposure

被引：84

作者：

McElhatton, PR ^{[1
]}

Bateman, DN

Evans, C

Pughe, KR

Thomas, SHL

机构：

[1] Natl Teratol Informat Serv, Reg Drug & Therapeut Ctr, Wolfson Unit, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England

[2] Royal Edinburgh NHS Trust, Scottish Poisons Informat Bur, Edinburgh EH3 9YW, Midlothian, Scotland

来源：

LANCET | 1999年 / 354卷 / 9188期

关键词：

D O I：

10.1016/S0140-6736(99)02423-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Prospective follow-up of 136 babies exposed to ecstasy in utero indicated that the drug may be associated with a significantly increased risk of congenital defects (15.4% [95% CI 8.2-25.4]). Cardiovascular anomalies (26 per 1000 livebirths [3.0-90.0]) and musculoskeletal anomalies (38 per 1000 [8.0-109.0]) were predominant.

引用

页码：1441 / 1442

页数：2